Trials / Completed
CompletedNCT04590976
Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research
Patients' Preferences in the Treatment of Hormone-sensitive Metastatic Prostate Cancer: a Discrete Choice Experiment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (actual)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Systemic therapy (i.e Androgen Deprivation Therapy with Docetaxel, Enzalutamide, Apalutamide or Abiraterone Acetate) has increased overall survival in men with hormone-sensitive metastatic prostate cancer. Novel local cytoreductive treatments and metastasis directed therapy are being evaluated, these can confer additional harm, but might improve survival. We aim to elicit men's preferences for and willingness to accept trade-offs between potential improved survival and cytoreductive treatment risks using a 'discrete choice experiment'.
Detailed description
OBJECTIVES: To determine the attributes associated with treatment that are most important to men with hormone-sensitive metastatic prostate cancer (mPCa). To determine men's preferences for, and trade-offs between, the attributes (survival and side-effects) of different treatment options in metastatic prostate cancer including systemic therapy, local and metastases-directed physical therapies. PHASE: Prospective multi-centre observational cohort DESIGN: Discrete choice experiment, single-visit, electronic questionnaire design SAMPLE SIZE: Multi-centre Stage (Stage 3) n = 300 patients POPULATION: Men with newly-diagnosed metastatic prostate cancer who have not consented to a form of local cytoreductive or metastasis directed therapy.
Conditions
- Prostate Cancer Metastatic
- Radiotherapy Side Effect
- Surgery
- Urologic Cancer
- Quality of Life
- Patient Satisfaction
- Health Care Utilization
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Semi-Structured Interview Healthcare Professional | Interview |
| OTHER | Semi-Structured Interview Patients | Interview |
| OTHER | Think Aloud Interview Patients | Interview |
| OTHER | Discrete Choice Experiment (DCE) Patients | DCE Questionnaire |
Timeline
- Start date
- 2020-12-03
- Primary completion
- 2023-02-01
- Completion
- 2023-02-01
- First posted
- 2020-10-19
- Last updated
- 2023-02-08
Locations
35 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04590976. Inclusion in this directory is not an endorsement.